VILLA, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 6.077
EU - Europa 2.523
AS - Asia 1.028
Continente sconosciuto - Info sul continente non disponibili 7
SA - Sud America 6
AF - Africa 2
OC - Oceania 2
Totale 9.645
Nazione #
US - Stati Uniti d'America 5.977
IT - Italia 661
DE - Germania 389
SG - Singapore 388
IE - Irlanda 343
SE - Svezia 302
CN - Cina 279
RU - Federazione Russa 273
UA - Ucraina 190
HK - Hong Kong 185
GB - Regno Unito 110
CA - Canada 99
FI - Finlandia 63
AT - Austria 57
VN - Vietnam 56
DK - Danimarca 41
FR - Francia 35
ID - Indonesia 31
IN - India 29
TR - Turchia 18
BE - Belgio 17
NL - Olanda 14
IL - Israele 12
IR - Iran 8
EU - Europa 5
TW - Taiwan 5
ES - Italia 4
JP - Giappone 4
BG - Bulgaria 3
BR - Brasile 3
GR - Grecia 3
KR - Corea 3
PK - Pakistan 3
PL - Polonia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AU - Australia 2
CH - Svizzera 2
CL - Cile 2
CZ - Repubblica Ceca 2
IQ - Iraq 2
MU - Mauritius 2
PT - Portogallo 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
AZ - Azerbaigian 1
HR - Croazia 1
HU - Ungheria 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MK - Macedonia 1
MX - Messico 1
MY - Malesia 1
NO - Norvegia 1
PE - Perù 1
SA - Arabia Saudita 1
Totale 9.645
Città #
Ann Arbor 1.457
Fairfield 663
Woodbridge 518
Houston 368
Wilmington 348
Singapore 343
Dublin 332
Frankfurt am Main 309
Ashburn 271
Chandler 269
Milan 243
Seattle 234
Cambridge 213
Hong Kong 183
Jacksonville 179
Santa Clara 162
New York 149
Princeton 148
Dearborn 98
Altamura 89
Lawrence 68
Nanjing 67
Vienna 57
Ottawa 47
San Diego 42
Guangzhou 36
Beijing 35
Jakarta 30
Lachine 29
Fremont 28
Helsinki 27
Dong Ket 26
Grafing 24
Shanghai 20
Andover 19
Nanchang 17
Boardman 14
Brussels 14
Hebei 14
Chicago 13
Shenyang 13
Toronto 13
Norwalk 12
Los Angeles 11
Jiaxing 10
Rome 10
Kocaeli 9
London 9
Carate Brianza 8
Paris 8
Tianjin 8
Edmonton 7
Falls Church 7
Fuzhou 7
Monza 7
Munich 7
Jinan 6
Kiev 6
San Mateo 6
Bonndorf 5
Florence 5
Hefei 5
Hyderabad 5
Kunming 5
Lappeenranta 5
Taizhou 5
Cinisello Balsamo 4
Dallas 4
Gambolò 4
Gessate 4
Kaohsiung 4
Marche 4
Melegnano 4
Naples 4
Napoli 4
Stezzano 4
Trento 4
Washington 4
Bareggio 3
Brescia 3
Busto Arsizio 3
Daejeon 3
Delhi 3
Detroit 3
Gelsenkirchen 3
Kardzhali 3
Kilburn 3
Lyngby 3
Maniago 3
Modena 3
Pavia 3
Pianoro 3
Potenza 3
Shaoxing 3
Udine 3
Vimercate 3
Zanjan 3
Aachen 2
Amsterdam 2
Ansbach 2
Totale 7.513
Nome #
CHRNA2 and nocturnal frontal lobe epilepsy: Identification and characterization of a novel loss of function mutation 355
Analysis of human papillomavirus (HPV) 16 variants associated with cervical infection in Italian women 307
Simultaneous overexpression of human E5NT and ENTPD1 protects porcine endothelial cells against H2O2-induced oxidative stress and cytotoxicity in vitro 288
Potassium channels in the neuronal homeostasis and neurodegenerative pathways underlying Alzheimer's disease: An update 235
Long Non-Coding RNAs and Related Molecular Pathways in the Pathogenesis of Epilepsy 234
A novel KCNJ2 mutation identified in an autistic proband affects the single channel properties of Kir2.1 230
Understanding the basis of Ehlers-Danlos syndrome in the era of the next-generation sequencing 228
Identification of two mutations in cis in the SCN1A gene in a family showing genetic epilepsy with febrile seizures plus (GEFS+) and idiopathic generalized epilepsy (IGE) 219
The synergistic relationship between Alzheimer's disease and sleep disorders: An update 215
Molecular and imaging biomarkers in Alzheimer’s disease: A focus on recent insights 215
Variants in CHRNB2 and CHRNA4 identified in patients with insular epilepsy 213
Emerging roles of long non-coding RNAs in the pathogenesis of Alzheimer's disease 198
Patient-Derived Induced Pluripotent Stem Cells (iPSCs) and Cerebral Organoids for Drug Screening and Development in Autism Spectrum Disorder: Opportunities and Challenges 198
Potassium channels and human epileptic phenotypes: An updated overview 191
Genetic architecture and molecular, imaging and prodromic markers in dementia with lewy bodies: State of the art, opportunities and challenges 161
From genotype to phenotype: two cases of genetic frontotemporal lobar degeneration with premorbid bipolar disorder 155
Progranulin gene variability and plasma levels in bipolar disorder and schizophrenia 153
BAG1 is a protective factor for sporadic frontotemporal lobar degeneration but not for Alzheimer's disease 148
Role of OLR1 and its regulating hsa-miR369-3p in Alzheimer's disease: genetics and expression analysis 147
GSK3β genetic variability in patients with Multiple Sclerosis 145
Can SARS-CoV-2 Infection Exacerbate Alzheimer’s Disease? An Overview of Shared Risk Factors and Pathogenetic Mechanisms 144
Cell-dependent kinase inhibitor 2A and 2B genetic variability in patients with Alzheimer's disease 143
Expression and genetic analysis of miRNAs involved in CD4+ cell activation in patients with multiple sclerosis 142
Expression of the transcription factor Sp1 and its regulatory hsa-miR-29b in peripheral blood mononuclear cells from patients with Alzheimer's disease 139
Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis 139
Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion: late-onset psychotic clinical presentation 135
Novel missense progranulin gene mutation associated with the semantic variant of primary progressive aphasia 134
Ehlers-Danlos Syndrome classical type: A novel COL5A2 missense mutation with possible additive effect of a COL5A1 stop-gain mutation in a strongly correlated phenotype 134
A novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia 134
C9ORF72 hexanucleotide repeat expansion is a rare cause of schizophrenia 132
C9ORF72 hexanucleotide repeat expansion as a rare cause of bipolar disorder 132
Progranulin gene variability influences the risk for bipolar I disorder, but not bipolar II disorder 130
A novel role of cardiac inwardly rectifying potassium channels explaining autonomic cardiovascular dysfunctions in a cuprizone-induced mouse model of multiple sclerosis 129
Candidate gene analysis of selectin cluster in patients with multiple sclerosis 129
Circulating miRNAs as potential biomarkers in Alzheimer’s disease 123
Expression of the transcription factor Sp1 and its regulatory hsa-miR-29b in peripheral blood mononuclear cells from patients with Alzheimer’s disease 121
Role of hnRNP-A1 and miR-590-3p in neuronal death: genetics and expression analysis in patients with Alzheimer disease and frontotemporal lobar degeneration 119
Lymphocyte-activation gene 3 (LAG3) protein as a possible therapeutic target for Parkinson’s disease: Molecular mechanisms connecting neuroinflammation to α-synuclein spreading pathology 113
Genetics and expression analysis of the specificity protein 4 gene (SP4) in patients with Alzheimer's disease and frontotemporal lobar degeneration 109
Immunoreactivity of muscarinic acetylcholine M2 and serotonin 5-HT2B receptors, norepinephrine transporter and kir channels in a model of epilepsy 109
FUS/TLS genetic variability in sporadic frontotemporal lobar degeneration 107
Ehlers-Danlos syndromes and epilepsy: An updated review 106
Epileptic seizures in autosomal dominant forms of Alzheimer's disease 106
Causal Frontotemporal Lobar Degeneration mutations: a novel MAPT mutation associated with the clinical phenotype of Progressive nonfluent Aphasia 104
Unraveling the role of inwardly rectifying potassium channels in the hippocampus of an Aβ(1-42)-infused rat model of Alzheimer's disease 104
Rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells in patients with alzheimer's disease 103
TSPO Modulates Oligomeric Amyloid-β-Induced Monocyte Chemotaxis: Relevance for Neuroinflammation in Alzheimer's Disease 99
Is KIF24 a genetic risk factor for Frontotemporal Lobar Degeneration? 99
GRN variability contributes to sporadic frontotemporal lobar degeneration 99
Conditioned Medium of Mesenchymal Stromal Cells Loaded with Paclitaxel Is Effective in Preclinical Models of Triple-Negative Breast Cancer (TNBC) 98
C9ORF72 repeat expansion is not detected in patients with multiple sclerosis 97
Investigating cardiac morphological alterations in a pentylenetetrazol-kindling model of epilepsy 95
The progranulin (GRN) Cys157LysfsX97 mutation is associated with nonfluent variant of primary progressive aphasia clinical phenotype 91
Neuronal nitric oxide synthase C276T polymorphism increases the risk for frontotemporal lobar degeneration 91
Genetics and expression analysis of Sp4 transcription factor in patients with Alzheimer’s disease and frontotemporal lobar degeneration. 90
Circulating miRNAs as potential biomarkers in Alzheimer's disease 90
Candidate gene analysis of SPARCL1 gene in patients with multiple sclerosis 90
Intrathecal levels of IL-6, IL-11 and LIF in Alzheimer's disease and frontotemporal lobar degeneration 90
Novel exon 1 progranulin gene variant in Alzheimer's disease 84
DCUN1D1 is a risk factor for frontotemporal lobar degeneration 84
MCP-1 A-2518G polymorphism: Effect on susceptibility for frontotemporal lobar degeneration and on cerebrospinal fluid MCP-1 levels 79
CCL8/MCP-2 association analysis in patients with Alzheimer's disease and frontotemporal lobar degeneration 77
Causal frontotemporal lobar degeneration mutations: a novel mutation in MAPT associated with non-fluent progressive aphasia phenotype 75
Transcription factor Sp1 is regulated by hsa-miR-29b in peripheral blood mononuclear cells from patients with Alzheimer’s disease 72
Candidate gene analysis of semaphorins in patients with Alzheimer's disease 72
Exome Sequencing in an ADSHE Family: VUS Identification and Limits 69
Arylsulfatase a (Asa) in parkinson’s disease: From pathogenesis to biomarker potential 66
A 45-year-old Italian male with p.(Gly1815Ser) FBN1 mutation causing a mild variant of Marfan syndrome: A case study 65
The NOS3 G894T (Glu298Asp) polymorphism is a risk factor for frontotemporal lobar degeneration 61
Tlr-mediated signal transduction and neurodegenerative disorders 61
Biomarkers for alzheimer’s disease: Where do we stand and where are we going? 56
Multi-omics for the understanding of brain diseases 54
Genetics and expression analysis of the transcription factor Sp4 in patients with Alzheimer’s disease and frontotemporal lobar degeneration. 53
Microfluidic platforms to unravel mysteries of alzheimer’s disease: How far have we come? 51
Antioxidants in Alzheimer’s Disease: Current Therapeutic Significance and Future Prospects 47
Epigenetic Peripheral Biomarkers for Early Diagnosis of Alzheimer's Disease 45
Molecular Investigations of Protein Aggregation in the Pathogenesis of Amyotrophic Lateral Sclerosis 45
Expression and genetic analysis of microRNAs involved in multiple sclerosis 45
Psychosis in Parkinson’s Disease: A Lesson from Genetics 42
Homology Modelling, Molecular Docking and Molecular Dynamics Simulation Studies of CALMH1 against Secondary Metabolites of Bauhinia variegata to Treat Alzheimer’s Disease 39
Evaluating [18F]FDG and [18F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models 37
Ocular vascular changes: Choroidal thickness as an early biomarker for Alzheimer’s disease? 37
Epigenetics in Alzheimer’s Disease: A Critical Overview 34
Influence of DUX4 Expression in Facioscapulohumeral Muscular Dystrophy and Possible Treatments 33
New Insights into Molecular Mechanisms Underlying Neurodegenerative Disorders 28
Edaravone: A Novel Possible Drug for Cancer Treatment? 25
Insights into Dysregulated Neurological Biomarkers in Cancer 19
Muscle Involvement in Amyotrophic Lateral Sclerosis: Understanding the Pathogenesis and Advancing Therapeutics 18
From Brain to Muscle: The Role of Muscle Tissue in Neurodegenerative Disorders 11
Totale 10.168
Categoria #
all - tutte 37.673
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.673


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.050 0 0 0 0 130 154 213 131 160 102 114 46
2020/20212.102 104 234 190 217 145 194 148 188 146 191 152 193
2021/20221.208 148 150 160 100 82 135 60 55 45 40 77 156
2022/20231.497 188 436 149 93 89 244 15 78 111 26 44 24
2023/20241.146 44 41 35 111 123 273 179 34 137 18 20 131
2024/20251.131 165 379 184 143 260 0 0 0 0 0 0 0
Totale 10.168